Abeona Therapeutics Inc
Abeona Therapeutics Inc (ABEO) Covered Calls
As of September 25, 2026, ABEO has 3 covered call opportunities in the coming three months. Return ranges from 10.3 to 31.1% until expiration. Annualized return ranges from 64.1 to 163.6%. The nearest expiration is October 16, 2026. Maximum potential profit is $172.
Read more
Running ABEO covered calls helps you generate consistent income from Abeona Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Abeona Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ABEO covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ABEO stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ABEO covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Abeona Therapeutics Inc covered call is worth writing.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Income-focused investors, long-term ABEO holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ABEO covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Abeona Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile29.76% Subdued
- Market cap (M$)303
- 52 weeks high-30.85%
- 52 weeks low32.25%
- Analyst recommendationStrong Buy
1.00 - Target price$18.88
256.90% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.12
- EPS growth next 5 years-27.34%
As of September 25, 2026
| 2026-10-16 | 23 | 6.00 | 8.50 | 0.10 | 0.25 | 57.00 | 10.31 | 163.57 | -1.81 | +0.33 | 390 | 0.15 |
| 2026-12-18 | 86 | 7.00 | 26.58 | 0.20 | 4.90 | 167.00 | 30.20 | 128.17 | -3.62 | +0.70 | 1,661 | 4.70 |
| 2027-03-19 | 177 | 7.00 | 26.58 | 0.25 | 2.25 | 172.00 | 31.10 | 64.14 | -4.52 | +0.54 | 29 | 2.00 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best ABEO covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→